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ABSTRACT
Infantile Krabbe disease results in the accumulation of
lipid-raft-associated galactosylsphingosine (psychosine),
demyelination, neurodegeneration and premature death.
Recently, axonopathy has been depicted as a contributing
factor in the progression of neurodegeneration in the Twitcher
mouse, a bona fide mouse model of Krabbe disease. Analysis of
the temporal-expression profile of MBP (myelin basic protein)
isoforms showed unexpected increases of the 14, 17 and 18.5
kDaisoformsinthesciaticnerveof 1-week-oldTwitchermice,
suggesting an abnormal regulation of the myelination
processduring early postnatal life inthismutant.Ourstudies
showed an elevated activation of the pro-apoptotic protease
caspase 3 in sciatic nerves of 15- and 30-day-old Twitcher
mice, in parallel with increasing demyelination. Interestingly,
while active caspase 3 was clearly contained in peripheral
axons at all ages, we found no evidence of caspase accumul-
ation in the soma of corresponding mutant spinal cord
motor neurons. Furthermore, active caspase 3 was found not
only in unmyelinated axons, but also in myelinated axons of
the mutant sciatic nerve. These results suggest that axonal
caspase activation occurs before demyelination and follow-
ing a dying-back pattern. Finally, we showed that psychosine
was sufficient to activate caspase 3 in motor neuronal cells
in vitro in the absence of myelinating glia. Taken together,
these findings indicate that degenerating mechanisms
actively and specifically mediate axonal dysfunction in
Krabbe disease and support the idea that psychosine is a
pathogenic sphingolipid sufficient to cause axonal defects
independently of demyelination.
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INTRODUCTION
Krabbe disease or globoid cell leukodystrophy is a rare auto-
somal recessive disease caused by the deficiency of b-GALC
(galactosylceramidase) which results in the accumulation of
galactosylsphingosine (psychosine) (Igisu and Suzuki, 1984;
Suzuki, 1998; Wenger et al., 2000). Most commonly, Krabbe
disease is an infantile variant form where symptoms include
muscle rigidity and atrophy, hearing and vision defects,
developmental regression and, ultimately, fatality before
2 years of age (Aicardi, 1993). Demyelination is the most
common hallmark of Krabbe disease. However, other neuro-
pathological defects, including axonal dysfunction, have
been shown in the Twitcher mouse, a natural mouse model
of Krabbe disease (Galbiati et al., 2009; Castelvetri et al.,
2011). While new studies are beginning to shed light on the
mechanisms of neurodegeneration in the Twitcher mouse,
the temporal pattern of axonal degeneration and the patho-
genic mechanism mediating axonal dysfunction are largely
uncharacterized.
Axonal loss is considered as the main cause for permanent
neurological handicap in many myelin disorders (Bjartmar et al.,
1999; Dutta and Trapp, 2007). We found that peripheral axons
are abnormally phosphorylated in the Twitcher mouse, with
average diameters decreased to approx. 3 mm (L. Castelvetri
and E. R. Bongarzone, unpublished data). Mutant peripheral
axons also develop swellings and varicosities (Castelvetri et al.,
2011). Thesestructural defectsparallel developmentaldelays in
mutant mice to acquire postural reflexes, limb strength and
maturation of locomotor memory (Olmstead, 1987). All
together, these findings indicate a progressive impairment
of axonal function, which may include axonal instability,
defective axonal transport, deregulated ion channels function
and/or abnormal interaction with myelin sheaths.
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asnneuro.org / Volume 3 (4) / art:e00066 213Caspase 3 is a cysteine effector protease that is activated
by upstream proteases during late stages of apoptosis and
cell death (Okouchi et al., 2007). Caspase activation may be
caused by a variety of stimuli, including mitochondrial dys-
function, oxidative stress and irregular calcium homoeostasis
(Chan, 2001, Orrenius et al., 2003; Polster and Fiskum, 2004;
Culmsee and Landshamer, 2006). Caspase 3 activation has
been shown in many neurodegenerative diseases, including:
Alzheimer’s disease, MPTP (1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine)-induced Parkinsonian syndrome and ALS
(amyotrophic lateral sclerosis) (Martin, 1999; Turmel et al.,
2001; Rohn et al., 2002). Oligodendrocyte precursor cells and
neurons treated exogenously with psychosine also showed
higher levels of active caspase-3, suggesting that this
sphingolipid facilitates apoptosis (Giri et al., 2006; Castelvetri
et al., 2011). Interestingly, the protease activity of caspase 3
seems to play a role in axonal dysfunction in trophic depriva-
tion and dendritic pruning (Nikolaev et al., 2009; Schoenmann
et al., 2010), axonal degeneration in experimental allergic
encephalomyelitis (Ahmed et al., 2002), trauma (Chen et al.,
2004), proteolysis of spectrin (Reeves et al., 2010) and
retrograde fast axonal transport (Morfini et al., 2007).
In the present study, we examined the temporal activation
of caspase 3 in the Twitcher spinal cord and sciatic nerve in
the context of demyelination.
MATERIALS AND METHODS
Animals
Twitcher heterozygous (C57Bl/6J) and WT (wild-type) (C57Bl/
6J) mice (Jackson Laboratory) were maintained under
standard housing conditions. The Animal Care and Use Com-
mittee at the University of Illinois, Chicago approved all
animal experiments. Twitcher mice were identified by PCR as
previously described (Dolcetta et al., 2006).
Antibodies and chemicals
Antibodies used were: total caspase 3 (Cell Signaling), Active
aspase 3 (Cell Signaling), Actin (Sigma), MBP (myelin basic
protein) (a gift from Dr Anthony Campagnoni, University of
California, Los Angeles), APC (adenomatous polyposis coli;
Millipore), NF-H (neurofilament heavy chain; Cell Signaling),
and neurofilament light chain DA2 (Cell Signaling). Isolectin
IB4-Alexa FluorH 488 was from Invitrogen.
Electrophysiology
Sciatic nerve MCV (motor conduction velocity) was assessed
according to previously described techniques (Dolcetta et al.,
2005). Briefly, CMAP (compound motor action potential) was
obtained by stimulating the nerve at the ankle and ischiatic
notch with a pair of needle electrodes and recording in distal
hind-limb muscles. The active electrode was placed in the
middle of plantar muscles, whereas the reference was inserted
subcutaneously in the second digit. MCV was measured by
dividing the distance between the two points of stimulation
by the difference between proximal and distal CMAP latencies.
F-waves were recorded from proximal nerve segments and
motor roots with the same montage as described for MCV
(Toyoshima et al., 1986). cMEPs (cortical motor evoked
potentials) were elicited with a pair of needle monopolar
electrodes through the mouse primary motor area (Chiba et al.,
2003). CCT (central conduction time), an index of the pro-
pagation time of stimulus-related volleys descending along
corticospinal tracts, was calculated as the difference between
the latency of the sMEP (spinal motor evoked potential), i.e.
latency of muscle responses to stimulate lumbar motor roots
electrically minus that of the cMEP.
Western blotting
Spinal cord and sciatic nerves were removed from WT and
Twitcher mice at postnatal days 7, 14–15 and 30. Tissues were
homogenized in protein lysis buffer containing: 20 mM Tris/
HCl, pH 7.4, 1% Triton X-100, 150 mM NaCl, 5 mM MgCl2,
1 mM PMSF, 2 mM sodium orthovanadate, 1 mM NaF and 300
nM okadaic acid. Samples were sonicated on ice and spun
down at 5000 rev./min for 5 min at 4˚C. The supernatant was
quantified using BCA Bradford assay (Bio-Rad). SDS/PAGE
was performed using 4–12% Bis-Tris gels (Invitrogen). Proteins
were transferred on to nitrocellulose membranes, blocked in
5% (w/v) non-fat dried skimmed milk powder, 1% BSA, 0.05%
Tween 20 in Tris/Glycine buffer and incubated in primary
antibodies at 4˚C overnight. Membranes were incubated
in secondary peroxidase-conjugated antibodies at room
temperature for 1 h. Proteins were visualized using enhanced
luminescence (Thermo Scientific) and quantified using ImageJ
software (NIH).
Immunohistochemistry
Mice were anaesthetized and perfused with saline followed by
4% (w/v) PFA (paraformaldehyde). Spinal cords and sciatic
nerves were extracted and further fixed in 4% PFA for 24 h.
Tissue was transferred to 20% sucrose for 24 h then embedded
and quickly frozen in OCT (optimal cutting temperature). Cryo-
sections (20 mm) were mounted on super-frost slides and
stored at 220˚C. Sections were dried at room temperature and
washed in PBS. DAB (diaminobenzidine) staining was per-
formed by first quenching sections for 10 min at room
temperature using 10% methanol and 10% H2O2 in PBS. ABC
secondary antibodies and substrate solution (Vectastain Elite)
was employed using manufacturer’s guidelines. DAB solution
(1%) was used for visualization. Sections were dehydrated
usinga gradient seriesofalcoholand xyleneand mounted with
Permount (Fisher). Sections for immunofluorescence were
dried at room temperature, washed in 16PBS, and blocked in
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Sections were incubated with primary antibodies in blocking
solution for 48 h and secondary antibodies (Alexa FluorH 488
and 555) for 2 h. Sections were mounted using Vectashield
mounting medium (Vector) and visualized using a Zeiss Meta
510 confocal microscope.
Cell culture
Motorneuronal NSC34 cells were grown in DMEM (Dulbecco’s
modified Eagle’s medium) supplemented with 5% FBS (fetal
bovine serum), penicillin/streptomycin(Gibco)and L-glutamine
(Gibco). Psychosine (Sigma), C6-ceramide (Sigma), and D-sphingosine
(Sigma) were resuspended in 0.001% ethanol.
Immunocytochemistry
Cells were grown on Matrigel
TM-treated coverslips. Cells were
fixed in 4% PFA/PBS, permeabilized in 0.1% Triton X-100 and
blocked with 4% BSA/PBS. Coverslips were incubated with
primary antibodies diluted in 1% BSA/PBS overnight at 4˚C.
Cells were incubated with secondary antibodies Alexa FluorH
488 and Alexa FluorH 555 in 1% BSA/PBS and mounted.
DNA fragmentation assay
NSC34 cells were collected by spinning down at 7000 rev./min for
5 min and washed with sterile PBS. DNA lysis buffer (0.5 mg/ml of
proteinase K in 1 M Tris, pH 7.9, 2 M NaCl, 500 mM EDTA and
20% SDS) was added to the pellet and incubated at 56˚C
overnight. After RNAse treatment, phenol purification of DNA
wasperformedand0.8mg ofDNAwasrunona 2%agarosegel.
Ethidium bromide-stained gels were visualized using a Bio-Rad
Chemi-Doc XRS with Quantity One 1D gel visualizing software.
Statistical analysis
Data were analysed using Student’s ttest. P,0.05 was considered
significant. Results are means of independent measurements
¡S.E.M.
RESULTS
Temporal analysis of MBP expression in the
Twitcher mouse
The Twitcher mouse is a natural occurring demyelinating
mouse model of KD where psychosine accumulates in the CNS
(central nervous system) and PNS (peripheral nervous system)
(Shinoda et al., 1987; Galbiati et al., 2009). Demyelination has
previously been shown to begin during the third and fourth
weeks in the Twitcher mouse (Nagara et al., 1982). At
postnatal day 30, the Twitcher spinal cord has abundant
microgliosis and reduction of MBP compared with age-
matched controls (Figures 1a and 1d). This is also observed in
the Twitcher sciatic nerve at the same age (Figures 1b, 1e, 1c
and 1f). Demyelination and the concurrent loss of MBPs and
axon insulation become compounding factors that likely lead
to slowed nerve conduction seen in the Twitcher mouse. Here,
we show a strong decrease in MCVs of the sciatic nerve and
an increase in spinal cord conduction latency (Figure 1g).
MCVs were ,30 m/s in the P30 WT sciatic nerve, compared
with ,5 m/s in the Twitcher. CCT increased from ,3m si n
the wild-type to ,7 ms in the Twitcher cord.
To determine the temporal pattern of MBP isoform loss
in the Twitcher mouse, spinal cord and sciatic nerves from
WT and Twitcher mice at ages P7, P15 and P30 were extracted
and homogenized for immunoblot analysis. We show a
decrease in all four isoforms (21, 18, 17 and 14 kDa) of MBP
in the P30 Twitcher spinal cord (Figures 2a and 2c) but not at
P7 and P15. Peripherally, there is a significant decrease in all
four MBP isoforms starting at P15 in the sciatic nerve of the
Twitcher mouse and continuing to P30 (Figures 2b and 2c).
Interestingly, the 14, 17 and 18 kDa MBP isoforms were
found significantly increased in the Twitcher mouse com-
pared with WT at 7 days of age (Figure 2C).
Active caspase 3 in the Twitcher spinal cord
Activation of caspase 3 has been shown to increase in
oligodendrocytes exposed to psychosine and in the brain of
Figure 1 Analysis of Twitcher P30 spinal cord and sciatic nerve
Confocal analysis of MBP and Isolectin-IB4 (IB4) immunostaining in the Twitcher (TWI) (a) and wild-type (WT) (d) spinal cord.
Magnification 6100. Double labelling in the TWI sciatic nerve (b, c, magnification 6200) reveals MBP loss and microglia activation
compared with WT littermate controls (e, f, magnification 6630). Sciatic nerve MCVs and CNS CCTs of the TWI mouse are compared
with WT controls (g).
Caspase activation in Twitcher
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215sick Twitcher mice (Giri et al., 2006; Galbiati et al., 2007b).
However, caspase 3 activation has not been reported in the
spinal cord and nerves of the Twitcher mouse. Caspase 3
activation is a natural process to eliminate unnecessary cells
during embryonic development. Interestingly, increased
numbers of neurons containing active caspase 3 were found
in the Twitcher spinal cord as early at birth (Figures 3a–3c
and 3e). Importantly, while active caspase 3 was observed
in cell bodies, it was also found in cell processes and axons in
the Twitcher spinal cord (Figure 3c and arrowheads
in Figure 3b).
Next, we examined the level of active caspase 3 in the
spinal cord at later stages of the disease. Figure 4 shows
positive staining of caspase 3 in longitudinal sections of the
Twitcher spinal cord compared with controls (Figures 4a and
4b). Interestingly, the strongest staining was localized to the
ventral funiculus region, which contains the anterior
corticospinal and lateral vestibulospinal tracts, better seen
in cross-sections in Figures 4(c) and 4(d). Active caspase 3
was observed clearly localized in axons (arrows in Figures 4e
and 4g). Finally, the relative abundance of active caspase 3 in
the cord was determined by quantitative immunoblotting
(Figure 5a). This analysis confirmed that active caspase 3 is
significantly increased in the Twitcher mouse spinal cord at
P30 (Figure 5b) but not at earlier time points.
Finally, we examined what cell types had active caspase
3 levels in the spinal cord. Immunohistochemical analyses
showed thatactivecaspase3 waslocalizedprimarilytoneuronal
Figure 2 MBP in the TWI and WT nervous system
Immunoblotting analysis of MBP isoforms (21, 18, 17 and 14 kDa) at P7, 14 and 30 of the TWI spinal cord (a) and sciatic nerve (b)
compared with WT controls. Quantifications of results show significant loss of all MBP isoforms at later stages in the disease, while
MBP isoforms 18, 17 and 14 are increased at P7 (c).
Figure 3 Immunohistochemistry of TWI spinal cord at P0
Active caspase 3 is visible in the TWI spinal cord (a). Caspase 3 is visible in neuronal processes (b) and cell bodies (c). This is compared
with normal caspase 3 activity observed in the P0 WT mice (d). Quantifications show elevated caspase 3 levels at birth (e).
Magnifications (a, d) 650; (b, c) 6400.
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www.asnneuro.org/an/003/an003e066add.htm). Co-localization
with NF-H further showed that caspase 3 was affecting
neuronal axons (Supplementary Figure S1, arrows). We did
not find significant levels of active caspase 3 staining in
oligodendrocytes, which were identified by reaction with the
antibody against APC, a marker for mature oligodendrocytes
(Supplementary Figure S2, white arrows; available at http://
www.asnneuro.org/an/003/an003e066add.htm). Active cas-
pase 3 was observed to co-localize sporadically with GFAP
(glial fibrillary acidic protein)-positive astroglial cells (Supple-
mentary Figure S2, blue arrow).
Active caspase 3 in the Twitcher sciatic nerve
To determine whether apoptotic pathways are activated in the
PNS of the Twitcher, mouse sciatic nerves were also analysed for
active caspase 3 levels. Confocal microscopy showed positive
caspase 3 staining at allthree time points in the Twitcher nerves;
however, reactivity became stronger only in P15 and P30 nerves
of the Twitcher mice (Figures 6a and 6c, compared with
littermate controls in Figures 6b and 6d). Interestingly, active
caspase 3 was strongly localized to axons (myelin sheaths were
marked by immunostaining against MBP, in red; Figure 6a).
Immunoblot analysis of nerve extracts (Figure 7a) confirmed a
significant increase in active caspase 3 levels in the sciatic nerve
starting at P14 and continuing throughout the disease
(Figure 7b). Interestingly, active caspase 3 was significantly
lower in mutant nerves at P7 (Figure 7b). Altogether, these
results suggest that, while the time points of significant increase
in active caspase 3 levels correlate with the loss of myelin
integrity in the sciatic nerve, activation of caspase 3 in axons
may also occur independently of demyelination.
Psychosine is sufficient to activate caspase 3 in
cultures of a motor neuronal cell line in the
absence of myelinating glia
Finally, to test if psychosine is a pathogenic molecule sufficient
to activate caspase 3 in neurons, we cultured differentiated
motor neuronal NSC34 cells in the presence or absence of
psychosine and in the absence of myelinating glial cells.
Incubation with 1 mM psychosine (Whitfield et al., 2001) for
24 h led to significant activation of caspase 3 (Figures 8a and
8b). Increasing psychosine levels to 5 mM further elevated
caspase levels, showing a dose-dependent response. This level
of caspase activation was similar that obtained when NSC34
cells were incubated with 30 mMC 6-ceramide, a strong
activator of caspases (Spinedi et al., 1998; Ravid et al., 2003).
Immunocytochemical detection of active caspase 3 in NSC34
cells (in green, Figure 8c) was observed in the cytoplasm and
neuronal processes of NSC34 cells (identified with antibodies
against neurofilament light chain, in red) 2 h after treatment
with 5 mM psychosine (Figure 8c). Exposing NSC34 cells to
psychosine for 2 h led to DNA fragmentation (Figure 8e).
Figure 4 Active caspase 3 in the TWI spinal cord
Active caspase 3 (aCasp3) (green) in longitudinal sections of the P30 TWI
spinal cord (a) compared with WT (b). Magnification 6200. Active caspase 3
in transverse sections of the ventral funiculus region of the spinal cord
shows caspase 3 in the TWI (c)a n dW T( d). Magnification 6400. Active
caspase 3 is localized to some axons ensheathed with MBP (red). Magnifi-
cation 61000.
Figure 5 Immunoblot analysis of active caspase 3 in the spinal cord
Inactive (iCaspase 3) and active caspase 3 (aCaspase 3) levels are shown in
WT and TWI spinal cord tissue at P7, 14 and 30 (a). Quantifications of fold
change in active/inactive caspase 3 levels are shown (b). n53.
Caspase activation in Twitcher
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Structural defects in axons of the Twitcher mouse suggest-
ing a dying-back neuropathy were previously observed by
our group (Castelvetri et al., 2011). We report here for the
first time that activation of pro-apoptotic protease caspase
3 is highly increased in central and peripheral mutant axons
before any sign of activation of the protease in neurons
or even glial bodies, providing further support to the
hypothesis of a dying-back mechanism. Our study also found
unprecedented early increases of some MBP isoforms,
suggesting abnormal myelination in peripheral nerves early
after birth.
Early increases in MBP expression suggest
abnormal myelination in the young sciatic nerve
Ever since Knud H. Krabbe described the first five cases of
this lysosomal storage disease in 1916 (Krabbe, 1916)
much work has been done to determine the underlying
pathogenic mechanism of this fatal disease. A central role
in pathogenesis has been attributed to psychosine (Suzuki,
1998), a galactosylsphingolipid that rapidly accumulates in
lipid rafts (White et al., 2009) and interferes in multiple
signalling pathways (Giri et al., 2006, 2008; White et al.,
2011). The Twitcher mouse, a natural mutant murine model
of Krabbe disease, has been an invaluable resource to
understand these processes, including demyelination and
other gliotic responses (Kobayashi et al., 1980; Takahashi and
Suzuki, 1984; Mikoshiba et al., 1985). From these pioneering
studies, it was concluded that myelination in the Twitcher
mouse is normal for the first 2–3 weeks of life, and
demyelination strikes later, between P20 and P25 (spinal
cord) and ,P20 (peripheral nerves).
In order to understand the correlation between demyelina-
tion, axonal damage and neuronal death, we first studied the
effects of disease on the abundance of each MBP isoform.
Products of the MBP gene are fundamental components of
peripheral and central myelin (Barbarese et al., 1978; de Ferra
et al., 1985; Boggs, 2006; Harauz et al., 2009). MBP loss
accompanies myelin degeneration in demyelinating diseases
such as multiple sclerosis and metachromatic leukodystrophy
diseases (Gendelman et al., 1985; Ramakrishnan et al., 2007).
Loss of function of the MBP gene in the Shiverer mouse also
causes a myelin formation defect (Bird et al., 1978). Because
of the functional impact of MBPs on myelin function and
their specificity to mark myelin sheaths, the abundance of
MBPs has been a very useful biochemical endpoint to study
myelin loss (Takahashi and Suzuki, 1984). Albeit the loss of
MBPs as a general marker of myelin has been evaluated
in sick Twitcher mice (Mikoshiba et al., 1985), individual
measurement of MBP isoforms has not been reported for the
Twitcher. Our studies showed significant decreases for each
Figure 6 Active caspase 3 in the TWI sciatic nerve
Caspase 3 (green) is localized to nerve fibres with different stages of MBP
loss (red) in the P15 TWI mouse (a, inset) compared with P15 WT mice (b).
This continues in the P30 TWI (c) compared with controls (d). Background
levels for TWI (A-488) (e) and TWI (A-546) (f) animals are also shown.
Magnification 6200.
Figure 7 Immunoblot analysis of active caspase 3 in the sciatic nerve
Inactive (iCaspase 3) and active caspase 3 (aCaspase 3) levels are shown in
WT and TWI sciatic nerve tissue at P7, 14 and 30 (a). Quantifications of fold
change in active/inactive caspase 3 levels are shown (b). n53.
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mutant but not in younger animals. Instead, reductions
of all MBP isoforms in the sciatic nerve were significant
at P15, earlier than previously described (Takahashi and
Suzuki, 1984). These data confirm that demyelination in
the Twitcher mutant begins as a peripheral insult ,10 days
before central damage. Unexpectedly, the abundance of
the 14, 17 and 18.5 kDa isoforms of MBP was significantly
increased in mutant sciatic nerves at P7. In the cord, the 14
and 17 kDa MBP isoforms were slightly increased as well, but
in a non-significant manner. This finding suggests either an
increase in Schwann cell proliferation or in the synthesis of
peripheral myelin. Previous studies using in vivo [
3H]thymidine
metabolic labelling showed a dysfunction in Twitcher Schwann
cells, which continued to proliferate in mutant nerves even
after demyelination (Komiyama and Suzuki, 1994). The reason
for this defect has never been clarified. We have previously
shown that psychosine accumulates in lipid rafts of the
mutant brain and sciatic nerve, disrupting raft architecture
(White et al., 2009). Accumulation of psychosine in P7 mutant
sciatic nerves is low in comparison with late stages of the
disease but significantly higher than age-matched WT nerves
(L. Castelvetri and E. R. Bongarzone, unpublished data). One
possible interpretation is that psychosine may exhibit dual
effects in a concentration-dependent manner: at low
concentrations, psychosine may facilitate myelination and/or
Schwann cells proliferation, likely facilitating raft-mediated
trophic signalling such as the PDGF (platelet-derived growth
factor) pathway, relevant for Schwann cell proliferation
(Yamada et al., 1996). As disease progresses and psychosine
accumulates, it becomes a neurotoxic sphingolipid, activating
death pathways in mature Schwann cells and causing
demyelination.
Caspase 3 is activated in mutant axons
independently of neuronal cell death
Various studies have shown evidence of an ongoing axonal and
neuronal dysfunction during demyelination in Krabbe disease
(Hogan et al., 1969; Jacobs et al., 1982; Dolcetta et al., 2006;
Galbiati et al., 2007a, 2007b, 2009; Escolar et al., 2009; Hofling
et al., 2009, Castelvetri et al., 2011). Interestingly, axonal
counting performed on cross-sections of Twitcher sciatic
nerves, perhaps the best region in this mutant where to study
axonalandmyelindamage, showedtheabsenceof axonal ‘loss’
(Jacobs et al., 1982). However, a recent re-evaluation of this
issue using longitudinal sections of mutant nerves clearly
showed the presence of structural alterations, including
swellings and breaks at early postnatal stages (Castelvetri
et al., 2011). This last study also showed absence of significant
levels of neuronal cell death in the spinal cord of the mutant,
at least until very late in the disease. In all, one possible
interpretation is that a dying back neuropathy affects this
mutant, with caspase 3 activation and damage to some axons
occurring before neuronal death.
To examine this possibility in more detail, immunoblotting
analyses for measuring changes in caspase activation were
performed and showed elevated levels of active caspase 3 in
mutant sciatic nerves as early as P15. This was coincident
with the sharp decrease in MCV (Dolcetta et al., 2006) the
infiltration of macrophages (Ohno et al., 1993; Taniike and
Suzuki, 1994) and demyelination. Furthermore, our analyses
demonstrated that in P15 mutant sciatic nerves active caspase
3 was mostly localized within axons. Active caspase 3 was
marginal or absent in neuronal bodies in the cord or Schwann
cell bodies in the nerve at P15. In fact, apoptotic cell bodies
were observed only at later stages using TUNEL (terminal
deoxynucleotidyl transferase-mediated dUTP nick-end
Figure 8 Caspase 3 in vitro
Immunoblot analysis of inactive and active caspase 3 levels in NSC34 cells treated with 1 and 5 mM psychosine (PSY) where 30 mM
C6-ceramide (C6-C) serves as the positive control (a). Quantifications of fold change in active/inactive caspase 3 levels are shown (b)
(n52). Active caspase 3 (aCasp3, green) is visible in 5 mM 24 PSY treated cells for 2 h (c) compared with vehicle controls also labelled
with neurofilament light chain (NF-L, red). Magnification 6200. (d). DNA fragmentation assay shows an increase in DNA fragments
when cells are treated with 1 and 5 mM PSY compared with untreated (UT), vehicle (VH) and 1 mM D-sphingosine (Sph) negative
controls where C6-C serves as a positive control (e).
Caspase activation in Twitcher
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219labelling) and therefore would not co-localize with active
caspase 3 at these ages (Castelvetri et al., 2011). Some staining
of caspase 3 was localized to GFAP positive astrocytes. This
likely represents sporadic apoptotic astroglial death. Its
contribution to the phenotype observed in the Twitcher mouse
is unknown. While the expectation was to find oligodendroglia
also expressing active caspase 3, our results showed very little
if any of this caspase active in this cell type. At late stages of
disease, oligodendrocytes may die of apoptosis (Bjartmar et al.,
1999; Taniike et al., 1999; Castelvetri et al., 2011). These results
may indicate that the death of oligodendrocytes in the Twitcher
mouse may be a late event in the disease, involving other
apoptotic/degenerative pathways. Active caspase 3 seemed to
accumulate in myelinated and demyelinated axons (axons with
strong punctate MBP immunostaining pattern), suggesting
that myelin is not a primary trigger for activation of the
caspase pathway in axons. Unmyelinated sciatic nerve C-fibres
(Kobayashi et al., 1988; Tanaka et al., 1989) may be undergoing
dying-back death in the Twitcher mouse along with fibres that
have undergone demyelination or even before demyelination
begins. Intriguingly, not all axons showed active caspase 3,
which also indicates that activation of the protease is selective
to a subset of fibres. An area of growing interest in axonal
degeneration is the role that microgliosis plays in regulating
axonal–myelin interactions. Our studies show uneven distri-
bution of macrophages (detected by binding of IB4 lectin)
throughoutthenervoussystem.Thereasonforthisdistribution
is not fully understood, although it may be caused by localized
cross-talk between macrophages and the damaged tissue.
Macrophages may well exert differential distress/trophic
signalling cascades, executing death pathways in some cell
types (Burguillos et al., 2011) while aiding in debris removal
and repair in others (Kondo et al., 2011). Further studies need
to address whether infiltrating macrophages in the Twitcher
nerve regulate the activation of caspase 3 in axons.
In the spinal cord, active caspase 3 staining was localized in
axons of the ventral funiculus region of the spinal cord, the
area containing the anterior corticospinal tract and the lateral
vestibulospinal tract. These tracts are descending motor path-
ways responsible for maintaining motor control of the lower
limbs(Ludolphet al.,1987;Ugawaet al.,1991). Thepresenceof
active caspase 3 in these axons suggests axonal distress, which
may be partly responsible for the defects seen in the hind limbs
in the Twitcher mouse. The molecular mechanism by which
caspase may exert a pathogenic effect in the Twitcher axon
is the current object of studies in our laboratory. Caspase
3-mediated axonopathy may involve axonal transport deregula-
tion, proteolysis of cytoskeletal components such as spectrin
and microtubule-associated Tau and/or deregulation of down-
stream proteases (Gamblin et al., 2003; Reeves et al., 2010;
Westphal et al., 2010). Immunostaining for caspase in the cord
of newborn mutant detected also increased levels of caspase 3
positive axons in the neonatal cord, indicating a premature
level of axonal stress in neonates. The relevance of this finding
is unclear, but it may ‘prime’ or ‘mark’ axons for further
structural damage seen at later stages. As psychosine builds up
and accumulates to toxic levels, neurons appear to activate
caspase 3, which eventually trigger an apoptotic-death
programme.
In conclusion, the work presented here shows activation of
axonal death in the form of active caspase 3 in the Twitcher
PNS (peripheral nervous system) and CNS. Our study
demonstrates that psychosine is sufficient to cause activation
of this protease in the absence of myelinating glia, strongly
underlining the potential role of this toxin in triggering this
pathogenic mechanism. The link between psychosine and the
defect described in this study could also involve other
partners such as ER (endoplasmic reticulum) stress, imbalance
of calcium or abnormal levels of ion channels (Orrenius et al.,
2003; Kurnellas et al., 2005). Mitochondrial dysfunction and
sequential cytochrome c release also can increase caspase 3
activation (Polster and Fiskum, 2004). Taken together, our
observations suggest a form of ‘dying back’ neuropathy in the
nervous system of the Twitcher mouse, likely regulated by the
levelsoftoxicpsychosine,inparallelwithabnormalmyelination
during early stages of the disease.
FUNDING
This work was partially supported by the National Institutes
of Health [grant number RNS065808A], the Morton Cure
Paralysis Foundation and the Board of Trustees at the
University of Illinois (to E.R.B.).
REFERENCES
Ahmed Z, Doward AI, Pryce G, Taylor DL, Pocock JM, Leonard JP, Baker D,
Cuzner ML (2002) A role for caspase-1 and -3 in the pathology of
experimental allergic encephalomyelitis: inflammation versus degenera-
tion. Am J Pathol 161:1577–1586.
Aicardi J (1993) The inherited leukodystrophies: a clinical overview. J Inherit
Metab Dis 16:733–743.
Barbarese E, Carson JH, Braun PE (1978) Accumulation of the four myelin
basic proteins in mouse brain during development. J Neurochem 31:779–
782.
Bird TD, Farrell DF, Sumi SM (1978) Brain lipid composition of the shiverer
mouse: genetic defect in myelin development. J Neurochem 31:387–
391.
Bjartmar C, Yin X, Trapp BD (1999) Axonal pathology in myelin disorders.
J Neurocytol 28:383–395.
Boggs JM (2006) Myelin basic protein: a multifunctional protein. Cell Mol Life
Sci 63:1945–1961.
BurguillosMA,DeierborgT,KavanaghE,PerssonA,HajjiN,Garcia-QuintanillaA,
Cano J, Brundin P, Englund E, Venero JL, Joseph B (2011) Caspase
signalling controls microglia activation and neurotoxicity. Nature 472:
319–324.
Castelvetri LC, Givogri MI, Zhu H, Smith B, Lopez-Rosas A, Qiu X, van
Breemen R, Bongarzone ER (2011) Axonopathy is a compounding factor
in the pathogenesis of Krabbe disease. Acta Neuropathol (Berl) 122:35–
48.
Chan PH (2001) Reactive oxygen radicals in signaling and damage in the
ischemic brain. J Cereb Blood Flow Metab 21:2–14.
Chen XH, Siman R, Iwata A, Meaney DF, Trojanowski JQ, Smith DH (2004)
Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1,
and caspase-3 in damaged axons following brain trauma. Am J Pathol
165:357–371.
Chiba A, Ohta Y, Oshio K, Inase M (2003) Motor evoked potentials in rats with
congenital hydrocephalus. Neurol Res 25:305–308.
B. Smith and others
220 E 2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.Culmsee C, Landshamer S (2006) Molecular insights into mechanisms of the
cell death program: role in the progression of neurodegenerative
disorders. Curr Alzheimer Res 3:269–283.
de Ferra F, Engh H, Hudson L, Kamholz J, Puckett C, Molineaux S, Lazzarini RA
(1985) Alternative splicing accounts for the four forms of myelin basic
protein. Cell 43:721–727.
Dolcetta D, Amadio S, Guerrini U, Givogri MI, Perani L, Galbiati F, Sironi L, Del
Carro U, Roncarolo MG, Bongarzone E (2005) Myelin deterioration in
Twitcher mice: motor evoked potentials and magnetic resonance imaging
as in vivo monitoring tools. J Neurosci Res 81:597–604.
Dolcetta D, Perani L, Givogri MI, Galbiati F, Amadio S, Del Carro U, Finocchiaro G,
Fanzani A, Marchesini S, Naldini L, Roncarolo MG, Bongarzone E (2006)
Design and optimization of lentiviral vectors for transfer of GALC expression
in Twitcher brain. J Gene Med 8:962–971.
Dutta R, Trapp BD (2007) Pathogenesis of axonal and neuronal damage in
multiple sclerosis. Neurology 68:S22–S31; discussion S43–S54.
Escolar ML, Poe MD, Smith JK, Gilmore JH, Kurtzberg J, Lin W, Styner M
(2009) Diffusion tensor imaging detects abnormalities in the corticosp-
inal tracts of neonates with infantile Krabbe disease. AJNR Am J
Neuroradiol 30:1017–1021.
Galbiati F, Basso V, Cantuti L, Givogri MI, Lopez-Rosas A, Perez N, Vasu C,
Cao H, van Breemen R, Mondino A, Bongarzone ER (2007a) Autonomic
denervation of lymphoid organs leads to epigenetic immune atrophy in a
mouse model of Krabbe disease. J Neurosci 27:13730–13738.
Galbiati F, Clementi G, Superchi D, Givogri MI, Bongarzone ER (2007b) Effects
of irradiation on the postnatal development of the brain in a genetic
mouse model of globoid cell leukodystrophy. Neurochem Res 32:377–
388.
Galbiati F, Givogri MI, Cantuti L, Rosas AL, Cao H, van Breemen R, Bongarzone
ER (2009) Combined hematopoietic and lentiviral gene-transfer therapies
in newborn Twitcher mice reveal contemporaneous neurodegeneration
and demyelination in Krabbe disease. J Neurosci Res 87:1748–1759.
Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M,
Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL
(2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles
in Alzheimer’s disease. Proc Natl Acad Sci USA 100:10032–10037.
Gendelman HE, Pezeshkpour GH, Pressman NJ, Wolinsky JS, Quarles RH,
Dobersen MJ, Trapp BD, Kitt CA, Aksamit A, Johnson RT (1985) A
quantitation of myelin-associated glycoprotein and myelin basic protein
loss in different demyelinating diseases. Ann Neurol 18:324–328.
Giri S, Khan M, Rattan R, Singh I, Singh AK (2006) Krabbe disease:
psychosine-mediated activation of phospholipase A2 in oligodendrocyte
cell death. J Lipid Res 47:1478–1492.
Giri S, Khan M, Nath N, Singh I, Singh AK (2008) The role of AMPK in
psychosine mediated effects on oligodendrocytes and astrocytes:
implication for Krabbe disease. J Neurochem 105:1820–1833.
Harauz G, Ladizhansky V, Boggs JM (2009) Structural polymorphism and
multifunctionality of myelin basic protein. Biochemistry 48:8094–8104.
Hofling AA, Kim JH, Fantz CR, Sands MS, Song SK (2009) Diffusion tensor
imaging detects axonal injury and demyelination in the spinal cord and
cranial nerves of a murine model of globoid cell leukodystrophy. NMR
Biomed 22:1100–1106.
Hogan GR, Gutmann L, Chou SM (1969) The peripheral neuropathy of
Krabbe’s (globoid) leukodystrophy. Neurology 19:1094–1100.
Igisu H, Suzuki K (1984) Progressive accumulation of toxic metabolite in a
genetic leukodystrophy. Science 224:753–755.
Jacobs JM, Scaravilli F, De Aranda FT (1982) The pathogenesis of globoid
cell leucodystrophy in peripheral nerve of the mouse mutant Twitcher.
J Neurol Sci 55:285–304.
Kobayashi T, Yamanaka T, Jacobs JM, Teixeira F, Suzuki K (1980) The Twitcher
mouse: an enzymatically authentic model of human globoid cell
leukodystrophy (Krabbe disease). Brain Res 202:479–483.
Kobayashi S, Katayama M, Satoh J, Suzuki K (1988) The Twitcher mouse.An
alteration of the unmyelinated fibers in the PNS. Am J Pathol 131:308–
319.
Komiyama A, Suzuki K (1994) Progressive dysfunction of Twitcher Schwann
cells is evaluated better in vitro than in vivo. Brain Res 637:106–113.
Kondo Y, Adams JM, Vanier MT, Duncan ID (2011) Macrophages counteract
demyelination in a mouse model of globoid cell leukodystrophy.
J Neurosci 31:3610–3624.
Krabbe K (1916) A new familial infantile form of diffuse brain sclerosis. Brain
39:74–114.
Kurnellas MP, Nicot A, Shull GE, Elkabes S (2005) Plasma membrane calcium
ATPase deficiency causes neuronal pathology in the spinal cord: a
potential mechanism for neurodegeneration in multiple sclerosis and
spinal cord injury. FASEB J 19:298–300.
Ludolph AC, Hugon J, Spencer PS (1987) Non-invasive assessment of the
pyramidal tract and motor pathway of primates. Electroencephalogr Clin
Neurophysiol 67:63–67.
Martin LJ (1999) Neuronal death in amyotrophic lateral sclerosis is apoptosis:
possible contribution of a programmed cell death mechanism.
J Neuropathol Exp Neurol 58:459–471.
Mikoshiba K, Fujishiro M, Kohsaka S, Okano H, Takamatsu K, Tsukada Y (1985)
Disorders in myelination in the Twitcher mutant: immunohistochemical
and biochemical studies. Neurochem Res 10:1129–1141.
Morfini G, Pigino G, Opalach K, Serulle Y, Moreira JE, Sugimori M, Llinas RR
Brady ST (2007) 1-Methyl-4-phenylpyridinium affects fast axonal
transport by activation of caspase and protein kinase C. Proc Natl Acad
Sci USA 104:2442–2447.
Nagara H, Kobayashi T, Suzuki K (1982) The Twitcher mouse: normal pattern
of early myelination in the spinal cord. Brain Res 244:289–294.
Nikolaev A, McLaughlin T, O’Leary DD, Tessier-Lavigne M (2009) APP binds
DR6 to trigger axon pruning and neuron death via distinct caspases.
Nature 457:981–989.
Ohno M, Komiyama A, Martin PM, Suzuki K (1993) Proliferation of microglia/
macrophages in the demyelinating CNS and PNS of Twitcher mouse.
Brain Res 602:268–274.
Okouchi M, Ekshyyan O, Maracine M, Aw TY (2007) Neuronal apoptosis in
neurodegeneration. Antioxid Redox Signal 9:1059–1096.
Olmstead CE (1987) Neurological and neurobehavioral development of the
mutant ‘Twitcher’ mouse. Behav Brain Res 25:143–153.
Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the
calcium-apoptosis link. Nat Rev Mol Cell Biol 4:552–565.
Polster BM, Fiskum G (2004) Mitochondrial mechanisms of neural cell
apoptosis. J Neurochem 90:1281–1289.
Ramakrishnan H, Hedayati KK, Lullmann-Rauch R, Wessig C, Fewou SN,
Maier H, Goebel HH, Gieselmann V, Eckhardt M (2007) Increasing
sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient
mice causes demyelination and neurological symptoms reminiscent of
human metachromatic leukodystrophy. J Neurosci 27:9482–9490.
Ravid T, Tsaba A, Gee P, Rasooly R, Medina EA, Goldkorn T (2003) Ceramide
accumulation precedes caspase-3 activation during apoptosis of A549
human lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol
284:L1082–L1092.
Reeves TM, Greer JE, Vanderveer AS, Phillips LL (2010) Proteolysis of
submembrane cytoskeletal proteins ankyrin-G and alphaII-spectrin
following diffuse brain injury: a role in white matter vulnerability at
Nodes of Ranvier. Brain Pathol 20:1055–1068.
Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E (2002) Caspase-
9 activation and caspase cleavage of tau in the Alzheimer’s disease brain.
Neurobiol Dis 11:341–354.
Schoenmann Z, Assa-Kunik E, Tiomny S, Minis A, Haklai-Topper L, Arama E,
Yaron A (2010) Axonal degeneration is regulated by the apoptotic
machinery or a NAD+-sensitive pathway in insects and mammals.
J Neurosci 30:6375–6386.
Shinoda H, Kobayashi T, Katayama M, Goto I, Nagara H (1987) Accumulation
of galactosylsphingosine (psychosine) in the Twitcher mouse: determina-
tion by HPLC. J Neurochem 49:92–99.
Spinedi A, Amendola A, Di Bartolomeo S, Piacentini M (1998) Ceramide-
induced apoptosis is mediated by caspase activation independently from
retinoblastoma protein post-translational modification. Biochem Biophys
Res Commun 243:852–857.
Suzuki K (1998) Twenty five years of the ‘psychosine hypothesis’: a personal
perspective of its history and present status. Neurochem Res 23:251–
259.
Takahashi H, Suzuki K (1984) Demyelination in the spinal cord of murine
globoid cell leukodystrophy (the Twitcher mouse). Acta Neuropathol
62:298–308.
Tanaka K, Nagara H, Kobayashi T, Goto I, Suzuki K (1989) The Twitcher mouse:
attenuated processes of Schwann cells in unmyelinated fibers. Brain Res
503:160–162.
Taniike M, Mohri I, Eguchi N, Irikura D, Urade Y, Okada S, Suzuki K (1999) An
apoptotic depletion of oligodendrocytes in the Twitcher, a murine model
of globoid cell leukodystrophy. J Neuropathol Exp Neurol 58:644–653.
Taniike M, Suzuki K (1994) Spacio-temporal progression of demyelination in
Twitcher mouse: with clinico-pathological correlation. Acta Neuropathol
88:228–236.
Toyoshima E, Yeager AM, Brennan S, Santos GW, Moser HW, Mayer RF (1986)
Nerve conduction studies in the Twitcher mouse (murine globoid cell
leukodystrophy). J Neurol Sci 74:307–318.
Caspase activation in Twitcher
E 2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
221Turmel H, Hartmann A, Parain K, Douhou A, Srinivasan A, Agid Y, Hirsch EC
(2001) Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine (MPTP)-treated mice. Mov Disord 16:185–189.
Ugawa Y, Rothwell JC, Day BL, Thompson PD, Marsden, CD (1991)
Percutaneous electrical stimulation of corticospinal pathways at the
level of the pyramidal decussation in humans. Ann Neurol 29:418–
427.
Wenger DA, Rafi MA, Luzi P, DattoJ, Costantino-Ceccarini E (2000) Krabbedisease:
genetic aspects and progress toward therapy. Mol Genet Metab 70:1–9.
Westphal D, Sytnyk V, Schachner M, Leshchyns’ka I (2010) Clustering of the
NCAM (neural cell adhesion molecule) at the neuronal cell surface induces
caspase-8- and -3-dependent changes of the spectrin meshwork required
for NCAM-mediated neurite outgrowth. J Biol Chem 285:42046–42057.
White AB, Givogri MI, Lopez-Rosas A, Cao H, van Breemen R, Thinakaran G,
Bongarzone ER (2009) Psychosine accumulates in membrane micro-
domains in the brain of Krabbe patients, disrupting the raft architecture.
J Neurosci 29:6068–6077.
White AB, Galbiati F, Givogri MI, Lopez Rosas A, Qiu X, van Breemen R,
Bongarzone ER (2011) Persistence of psychosine in brain lipid rafts is a
limiting factor in the therapeutic recovery of a mouse model for Krabbe
disease. J Neurosci Res 89:352–364.
Whitfield PD, Sharp PC, Taylor R, Meikle P (2001) Quantification of
galactosylsphingosine in the Twitcher mouse using electrospray ioniza-
tion-tandem mass spectrometry. J Lipid Res 42:2092–2095.
Yamada H, Martin P, Suzuki K (1996) Impairment of protein kinase C activity
in Twitcher Schwann cells in vitro. Brain Res 718:138–144.
Received 15 July 2011/7 September 2011; accepted 16 September 2011
Published as Immediate Publication 19 September 2011, doi 10.1042/AN20110019
B. Smith and others
222 E 2011 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.